🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Xuan Ge

City Of Hope National Medical Center

ORCID: 0000-0002-4703-4238

Also affiliated with City of Hope

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer”.

Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer

Cancer Immunology Immunotherapy(2023)10.1007/s00262-023-03470-y

N/A

0.809DataRank · unranked

22 citations

Weihua Guo, Susan E. Yost, Xuan Ge, Jin Sun Lee, Paul Frankel +12 more

Phase II Study Combining Pembrolizumab with Aromatase Inhibitor in Patients with Metastatic Hormone Receptor Positive Breast Cancer

Cancers(2022)10.3390/cancers14174279

N/A

0DataRank · unranked

12 citations

Susan E. Yost, Jin Sun Lee, Paul Frankel, Christopher Ruel, Yujie Cui +13 more

Predicting hyperglycemia among patients receiving alpelisib plus fulvestrant for metastatic breast cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.1060

N/A

0DataRank · unranked

2 citations

Carolyn E. Behrendt, Susan E. Yost, Niki Patel, Raynald Samoa, Daphne Stewart +6 more